OverviewChartNewsTraderScreen

DZ Bank Bonus Zert SNW 27.06.2025/  DE000DJ6R2S2  /

Frankfurt Zert./DZB
06/09/2024  21:34:37 Chg.-0.040 Bid21:58:06 Ask21:58:06 Underlying Strike price Expiration date Option type
96.590EUR -0.04% 96.580
Bid Size: 125		 96.630
Ask Size: 125		 SANOFI SA INHABER ... - EUR 27/06/2025 Call
GlobeNewswire 02/09 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 26/08 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 14/08 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 13/08 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 12/08 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 12/08 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 08/08 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 06/08 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 05/08 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 02/08 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 01/08 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 01/08 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 31/07 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 25/07 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 25/07 Europe lower premarket as earnings pour in
TeleTrader 25/07 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 25/07 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
GlobeNewswire 24/07 US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold...
GlobeNewswire 18/07 Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, Accord...
GlobeNewswire 17/07 Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transfor...
GlobeNewswire 12/07 FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows ...
GlobeNewswire 11/07 Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Upd...
GlobeNewswire 08/07 Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review ...
GlobeNewswire 03/07 Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients...
GlobeNewswire 03/07 Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD